appScorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
News & Opinions
Concord Drugs standalone net profit rises 7.14% in the December 2022 quarter
1 year ago•Business Standard
Stocks that will see action on September 9, 2022
2 years ago•The Hindu Businessline
Concord Drugs standalone net profit rises 475.00% in the September 2021 quarter
3 years ago•Business Standard
Concord Drugs standalone net profit rises 183.33% in the March 2021 quarter
3 years ago•Business Standard
Markets likely to witness lacklustre trade; eyes RBI’s monetary policy
3 years ago•The Hindu Businessline
Buzzing Stocks | HDFC, IRCTC, Zee Media, Canara Bank, Adani Ports, IRCON, VST Tillers
3 years ago•Moneycontrol